Brazil Profile Updated
May 12, 2022

Brazil Profile Updated

The Brazil profile in ClinRegs has been reviewed and updated with the following information:

Sources Added During this Update:

(Legislation) Constitutional Amendment No. 115 of February 10, 2022 (C-AmndtNo115 – Portuguese) (February 10, 2022)
National Congress

(Regulation) Normative Instruction No. 122 of March 9, 2022 – Provides Good Clinical Practice Inspection Procedures for Clinical Drug Trials (NormNo122 - Portuguese) (Effective April 1, 2022)
ANVISA, Ministry of Health

(Regulation) Resolution of the Collegiate Board – RDC No. 613 of March 9, 2022 (ResNo613 - Portuguese) (Effective April 1, 2022)
ANVISA, Ministry of Health

(Regulation) Resolution of the Collegiate Board of Directors - RDC No. 620 of March 9, 2022 (ResNo620 - Portuguese) (Effective April 1, 2022)
ANVISA, Ministry of Health

(Circular) Circular Letter No. 1/2022 - Use of an Electronic Mail System (E-mail) to Send Administrative Documents from Research Ethics Committees (CEP) (CLNo1-2022 - Portuguese) (February 7, 2022)
National Research Ethics Commission, Executive Secretariat of the National Health Council, Ministry of Health

(Guidance) Primer: Import Petition through LPCO (G-LPCOImprtPetition - Portuguese) (Version 3.2) (March 31, 2022)
ANVISA, Ministry of Health

(Form) Online Adverse Event Notification Form for Advanced Therapy Products (BRA-101 – Portuguese) (Current as of May 11, 2022)
ANVISA, Ministry of Health

(Document) Location of Available Documents on the ANVISA Portal (COPEC) (BRA-98 - Portuguese) (21th Edition) (March 10, 2022)
ANVISA, Ministry of Health

(Document) Pharmaceutical Inspection Co-operation Scheme (PIC/S) Brochure (BRA-100) (August 2019)
Pharmaceutical Inspection Co-operation Scheme (PIC/S)

(Document) Roadmap for Preparing Reports on Biobanks for Research Purposes (BRA-97 - Portuguese) (Version 02) (February 2, 2022)
National Research Ethics Commission, National Health Council, Ministry of Health

(Document) Technical Note No. 01/2022: Guidelines on Completing the Clinical Trial Submission Form (FAEC) Regarding the Expiration Date of Medicines and Products to be Imported for Conducting Clinical Trials in Brazil, Pursuant to RDC No. 9/2015 (BRA-95 - Portuguese) (February 2, 2022)
ANVISA, Ministry of Health

(Article) Advanced Research Therapy Product Imports: Pilot Project Migrates to Single Foreign Trade Portal (BRA-86 - Portuguese) (September 20, 2021)
ANVISA, Ministry of Health

(Article) Clinical trials: New Flow for Requesting a Global Transfer of Responsibility (BRA-96 - Portuguese) (Last Updated November 25, 2021)
ANVISA, Ministry of Health

(Article) Import No. 046/2021 – Inclusion of Products in ANVISA’s Administrative Treatment (BRA-94 - Portuguese) (Last Updated September 20, 2021)
Siscomex, Government of Brazil

(Webpage) ANVISA - Document Status Query Tool (BRA-102 - Portuguese) (Current as of May 11, 2022)
ANVISA, Ministry of Health

(Webpage) ANVISA - Obtain Authorization to Import Drug Substance (BRA-103 - Portuguese) (Last Updated March 4, 2022)
ANVISA, Ministry of Health

(Webpage) ANVISA - Public Service Center (BRA-99 - Portuguese) (Current as of May 11, 2022)
ANVISA, Ministry of Health

(Webpage) ANVISA - Request Product Import Licensing Subject to Sanitary Surveillance through LPCO (BRA-104 - Portuguese) (Last Updated March 14, 2022)
ANVISA, Ministry of Health

(Webpage) Brazil Platform (BRA-93 - Portuguese) (Last Updated November 23, 2020)
Ministry of Health

(Webpage) Learning to Export - Siscomex Single Portal (BRA-87 - Portuguese) (Last Updated December 29, 2021)
Siscomex, Government of Brazil

Sources Revised During this Update:

(Guidance) Inspection Guide on Good Clinical Practice (GCP) for Clinical Trials with Drugs and Biological Products - Inspection in Clinical Trial Centers (GuideNo35-2020 - Portuguese) (Version 2) (Effective January 27, 2022)
ANVISA, Ministry of Health

(Guidance) Inspection Guide on Good Clinical Practice (GCP) for Clinical Trials with Drugs and Biological Products - Inspection of Sponsors and Clinical Research Organization Representatives (ORPC) (GuideNo36-2020 - Portuguese) (Version 2) (Effective January 27, 2022)
ANVISA, Ministry of Health

(Document) 2020/2021 Activities Report - Coordination of Clinical Research on Medicines and Biological Products - COPEC (BRA-60 - Portuguese) (4th Edition) (March 28, 2022)
General Management of Medicines and Biological Products (GGMED), Coordination of Clinical Research in Medicines and Biological Products (COPEC), ANVISA

(Webpage) ANVISA - Ombudsman (BRA-35 - Portuguese) (Last Updated April 6, 2022)
ANVISA, Ministry of Health

Use the symbols below to refine your search
SymbolExplanation
No symbol At least one of the keywords must be present
Search example: serious adverse event
Result: Will contain serious and/or adverse and/or event
+ Leading plus sign indicates that the word must be present
Search example: serious +adverse event
Result: Will contain adverse and may contain serious and/or event
- Leading minus sign indicates that the word must not be present
Search example: serious adverse -event
Result: Will contain serious and/or adverse but won’t contain event
“ ” Exact phrase must be present
Search example: “serious adverse event”
Result: Will contain the phrase serious adverse event
Call for online focus group participants!
x

ClinRegs content is published in English. ClinRegs offers translations of the content through Google Translate, which is an external translation service. ClinRegs does not control the quality or accuracy of translated content and may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages.